Market InstituteMarket Institute
  • About
    • Who We Are
  • Research & Commentary
    • Papers
  • Events
  • Issues
  • Projects
    • International Overreach: When Global Standards Become U.S. Policy
    • Alzheimer’s
    • Letters
    • Political Cartoons

Research & Commentary

Articles

Lina Khan Spends Tax Dollars To Help EU Fine U.S. Companies

Federal Trade Commission Chair Lina Khan has continuously pushed policies Read more…

By admin, 2 years2 years ago
Articles

Advisory Committee on Immunization Practices Could Change Attitudes on Vaccines

In his latest article for RealClear Health, Market Institute President Read more…

By admin, 2 years2 years ago
Articles

Lina Khan and J.D. Vance Stand In the Way of Free Speech

Current antitrust actions led by figures like FTC Chair Lina Read more…

By admin, 2 years2 years ago
Events

The Doctors Forum

Market Institute hosted the Doctors Forum Fly-In, bringing physicians from Read more…

By admin, 2 years5 months ago
Events

Site Neutrality Happy Hour

Following the conclusion of the Doctors Forum, Market Institute hosted Read more…

By admin, 2 years5 months ago
Letter

Protecting America’s Innovation Leadership

The United States is at a critical juncture in its Read more…

By admin, 2 years2 years ago
Articles

Contra Lina Khan, ‘Serial Acquirers’ Help Small Compete With Big

The Federal Trade Commission (FTC) under Lina Khan and the Read more…

By admin, 2 years2 years ago
Articles

Don’t Let the Sun Go Down On Section 230, Expand It Instead

In the vast landscape of internet regulation, few laws have Read more…

By admin, 2 years2 years ago
Articles

The FTC Aims at Amazon, Hurts Small Businesses

In the world of e-commerce, few names resonate as strongly Read more…

By admin, 2 years2 years ago
Articles

Lina Khan Is the Miley Cyrus of Regulatory Policy

In recent years, the Federal Trade Commission (FTC) has taken Read more…

By admin, 2 years2 years ago

Posts pagination

Previous 1 … 17 18 19 … 37 Next
Recent Articles
  • Patents Play a Substantial Role In American Innovation June 4, 2026
  • Charles Sauer Discusses Medicare Advantage Reform on the Scott Sloan Show June 3, 2026
  • Section 232 Tariffs on Medical Devices are a Blunt Instrument for a Precision Industry June 3, 2026
  • Oz Cracks Down on Fraud. Medicare Advantage Next. May 31, 2026
  • Charles Sauer Discusses Alzheimer’s on the Lars Larson Show May 22, 2026
Recent Papers
  • The $135 Billion Lie: How Upcoding Is Draining Medicare and Medicaid
  • Why Does the Government Pay More for the Same Care?
  • The Practical, Constitutional, and Moral Case Against Social Media Regulation “For the Children”
  • Free Markets Under Attack from the Left and Right
  • A Free Market is a Fair Market

Loading

By adding your phone number, you opt in to receive text messages

Facebook
Twitter
YouTube

The Market Institute Follow

The Market Institute promotes the work of free market think tanks and associations. We Get Government Out of the Way.

MarketInstitute
Retweet on Twitter The Market Institute Retweeted
sayno2socialmed Coalition Against Socialized Medicine @sayno2socialmed ·
23h

Behind every breakthrough medicine is a patent system worth defending.

Today’s @JudiciaryGOP hearing made that case.

Failing to protect IP rights cedes America’s biotech edge to foreign competitors and leaves patients without access to the medicines they depend on.

Reply on Twitter 2062647581562327397 Retweet on Twitter 2062647581562327397 1 Like on Twitter 2062647581562327397 1 X 2062647581562327397
marketinstitute The Market Institute @marketinstitute ·
4 Jun

Patients don’t need Washington deciding what medical information they’re allowed to see.

DTC ads empower patients, spark doctor conversations, and help newer treatments compete.

Don’t keep patients in the dark.

Competitive Enterprise Institute @ceidotorg

Banning these advertisements outright - or regulating them into oblivion - would crush competition and keep patients in the dark. Consumers do not need
government bureaucrats gate-keeping medical information. CEI joins a coalition with @taxreformer, @AmerComm @CFEconomy

Reply on Twitter 2062592590201946407 Retweet on Twitter 2062592590201946407 Like on Twitter 2062592590201946407 X 2062592590201946407
marketinstitute The Market Institute @marketinstitute ·
4 Jun

PTAB was supposed to weed out bad patents.

Instead, it became a weapon for deep-pocketed corporations to attack innovators again and again. Hatch-Waxman already gives generic manufacturers a proven pathway to challenge patents and bring lower-cost medicines to market.

Serial

Reply on Twitter 2062565847835595228 Retweet on Twitter 2062565847835595228 Like on Twitter 2062565847835595228 X 2062565847835595228
Load More

  • About
  • Research & Commentary
  • Events
  • Issues
  • Projects